D
Seer, Inc. SEER
$1.95 -$0.02-1.02%
Recommendation
Sell
Prev Close
$1.97
Volume
166,975
Avg Vol (90D)
240,397
Market Cap
$117.77M
Dividend & Yield
--
52-Week Range
$1.56 - $2.63
P/E (TTM)
--
EPS (TTM)
-$1.39
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Seer (NASDAQ:SEER) Posts Earnings Results, Misses Estimates By $0.03 EPS
3/1/2025 - MarketBeat
Seer, Inc. (SEER) Q4 2024 Earnings Call Transcript
2/28/2025 - SeekingAlpha
Seer, Inc. (SEER) Q4 2024 Earnings Call Transcript
2/28/2025 - Seeking Alpha: Transcripts
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates
2/27/2025 - Zacks Investment Research
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook
2/27/2025 - Globe Newswire
Seer to Participate in the TD Cowen 45th Annual Health Care Conference
2/21/2025 - Globe Newswire
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
2/20/2025 - Globe Newswire
Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
2/13/2025 - Globe Newswire
Peapod Lane Capital LLC Takes Position in Seer, Inc. (NASDAQ:SEER)
2/13/2025 - Ticker Report
Peek Under The Hood: AVUS Has 13% Upside
2/12/2025 - ETF Channel
Omid Farokhzad Sells 8,068 Shares of Seer, Inc. (NASDAQ:SEER) Stock
2/7/2025 - MarketBeat
Seer, Inc. (NASDAQ:SEER) CEO Sells $18,072.32 in Stock
2/6/2025 - MarketBeat
Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
1/2/2025 - Globe Newswire
Charles Schwab Investment Management Inc. Trims Stock Position in Seer, Inc. (NASDAQ:SEER)
12/21/2024 - Ticker Report
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500
11/21/2024 - Globe Newswire
Mixed Financial Results and Strategic Partnerships Lead to Hold Rating for Seer Inc.
11/18/2024 - TipRanks Financial Blog
Seer to Participate in Upcoming November Investor Conferences
11/8/2024 - Globe Newswire
Seer, Inc. (SEER) Q3 2024 Earnings Call Transcript
11/7/2024 - Seeking Alpha: Transcripts
Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates
11/6/2024 - Zacks Investment Research
Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
11/6/2024 - Globe Newswire
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer's, Lung Cancer, and More at ASHG 2024
10/31/2024 - Globe Newswire
Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains?
10/30/2024 - Zacks Investment Research
Seer (SEER) to Release Quarterly Earnings on Wednesday
10/30/2024 - MarketBeat - AP News
Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer's, Population Health, and Xenotransplantation at HUPO 2024
10/21/2024 - Globe Newswire
Income Statement
Total Revenue (TTM)
$14.17M
EBITDA (TTM)
-$93.93M
EBIT (TTM)
-$100.10M
Net Income (TTM)
-$86.60M
Balance Sheet
Total Assets (Q)
$366.60M
Total Debt (Q)
$25.96M
Total Liabilities (Q)
$39.03M
Book Value Per Share (Q)
$5.54
Cash Flow
Cash from Operations (TTM)
-$46.11M
Cash from Investing (TTM)
$65.86M
Cash from Financing (TTM)
-$11.50M
Net Change in Cash (TTM)
$8.25M
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.43
7-Day Total Return
-4.41%
30-Day Total Return
-17.37%
60-Day Total Return
-21.05%
90-Day Total Return
2.63%
Year to Date Total Return
-16.31%
1-Year Total Return
8.33%
2-Year Total Return
-56.76%
3-Year Total Return
-83.59%
5-Year Total Return
--
52-week Low
Jul 09, 2024 - $1.56
52-week High
Nov 27, 2024 - $2.63
Valuation
Market Cap
$117.77M - Micro Cap
Enterprise Value
-$92.68M
Price/Sales (TTM)
8.22
Price/Book (Q)
0.36
Dividends and Shares
Shares Outstanding
59.09M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
seer.bio
Phone Number
650 453 0000
Address
3800 Bridge Parkway
Redwood City, CA 94065
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that... more
NASDAQ 03/14/2025 4:00PM Eastern Quotes delayed
Weiss Ratings